Enzolytics Inc (ENZC)

[FrankMD]

"Finally, ENZC has negotiated additional compensation in the form of a monthly management fee to be paid by Sagaliam Acquisition Corp (SAGA) to ENZC over a 30-month period following the close of the purchase of BGEN and VIRO. The funds will be used to facilitate the continued compliance of ENZC's OTC Market filing requirements, administration of the dividend payment of the 45 million SAGA share issuance received as part of the SAGA purchase transaction to the ENZC shareholders and the Company's development of a new business strategy to be implemented after the close of the sale of BGEN and VIRO. ENZC and SAGA have continued the process of documenting the Business Combination agreement and expect to provide further guidance later this month."
https://www.accesswire.com/772346/Virogentics-Inc-Provides-Update-on-African-Project-European-Medicine-Agency-Application-and-Clinical-Trials-for-Application-for-Type-2-Diabetes